INEX Pharmaceuticals Conference Call Notification

VANCOUVER, Nov. 17 /PRNewswire-FirstCall/ - Inex Pharmaceuticals Corporation announced today that it will hold a conference call and webcast on Thursday, November 17, 2005 at 1:30 p.m. PST (4:30 pm EST) to provide an update on developments at the Company including the November 17, 2005 announcement to spin-off the Company’s Targeted Immunotherapy assets.

About the Conference Call

-------------------------

To participate in the conference call, please dial 416-641-6130 or 1-866-226-1798. The call will be available for replay until November 27, 2005 by calling 416-695-5800 or 1-800-408-3053 and entering the pass code 3108540 followed by the number sign.

The live or archived webcast can be accessed through the Company’s website at www.inexpharm.com.

About INEX

INEX is a Canadian biopharmaceutical company developing and commercializing proprietary drugs and drug delivery systems to improve the treatment of cancer. Further information about INEX and can be found at www.inexpharm.com.

Contact Information Investors Ian Mortimer Vice President, Finance and Chief Financial Officer Phone: 604-419-3200 Email: info@inexpharm.com Website: www.inexpharm.com Media Karen Cook Boas James Hoggan & Associates Inc. Phone: 604-739-7500 Email: kcook@hoggan.com

Inex Pharmaceuticals Corporation

CONTACT: Investors: Ian Mortimer, Vice President, Finance and ChiefFinancial Officer, Phone: (604) 419-3200, Email: info@inexpharm.com,Website: www.inexpharm.com; Media: Karen Cook Boas, James Hoggan &Associates Inc., Phone: (604) 739-7500, Email: kcook@hoggan.com